United Health Products provided an update on the company’s FDA Premarket Approval application process. Due to further unanticipated delays in testing performed by external service providers, the company continues to await testing reports necessary for the preparation and filing of its revised PMA application. Testing of packaging activities completed to date have not indicated any adverse or unexpected results. There can be no assurance that the company’s PMA application will be approved.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on UEEC: